Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia

Clinical trial NCT04369469 · TERMINATED

Trial details

NCT number: NCT04369469
Sponsor: Alexion Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Severe Pneumonia Acute Lung Injury Acute Respiratory Distress Syndrome Pneumonia, Viral

Start date: 2020-05-10
Primary completion: 2021-02-08
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.